March 21st 2024
GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Do flavonoids or black tea lower risk of ovarian cancer?
November 6th 2014Studies of the impact of diet on risk of ovarian cancer are limited and their results unclear but a new report based on data from the Nurses’ Health Study (NHS) suggests a possible association between high intake of flavonoids and black tea and lower risk of the disease.
Read More
Could bisphosphonates reduce risk of bone metastasis in breast cancer?
October 16th 2014According to a recent study, low-dose oral bisphosphonates administered to prevent or treat postmenopausal osteoporosis may be associated with a lower risk of skeletal metastasis in patients with early- or more advanced-stage breast cancer.
Read More
Medicaid reimbursement impacts Pap, mammography screening
September 4th 2014An analysis of data from 46 states and the District of Columbia shows that the level of Medicaid reimbursement for office visits has an impact on likelihood of patient screening with Pap tests and other diagnostics for cancer.
Read More